Paras Ayurvedic Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Paras Ayurvedic Pharma Private Limited, with the most recent activity a…

1998-06-08 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
PA Paras Ayurvedic Pharma Private Limited
Open charges
4
1.95 cr
Closed charges
0
0.00
Total
4
1.95 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 3 1.91 cr
2 Janseva Sahakari Bank Ltd 1 4.00 Lakh
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100963693 Others 05 Jul 2024 - - 91.20 Lakh Open
100690541 Others 25 Jan 2023 - - 50.00 Lakh Open
100689841 Others 13 Jan 2023 06 Feb 2023 - 50.00 Lakh Open
90236202 Janseva Sahakari Bank Ltd 08 Jan 2003 - - 4.00 Lakh Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Paras Ayurvedic Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Paras Ayurvedic Pharma Private Limited (CIN: U24233MH1998PTC115252). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Paras Ayurvedic Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.